Empagliflozin Benefits on Kidney Disease Progression, Death Continue for 1 Year Post-Discontinuation
Will Herrington, MA, MBBS, MD, FRCP, FERACredit: Oxford UniversityPost-trial follow-up (PTFU) of the EMPA-KIDNEY trial has revealed that empagliflozin continues...
